Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Characteristics of persons with overactive bladder of presumed neurologic origin: Results from the boston area community health (BACH) survey.
Cognitive dysfunction in early multiple sclerosis: altered centrality derived from resting-state functional connectivity using magneto-encephalography.
Clinically meaningful performance benchmarks in MS: Timed 25-Foot Walk and the real world.
Could Intrathymic Injection of Myelin Basic Protein Suppress Inflammatory Response After Co-culture of T Lymphocytes and BV-2 Microglia Cells?
Psychiatric disorders in patients with multiple sclerosis.
A hematopoietic contribution to microhemorrhage formation during antiviral CD8 T cell-initiated blood-brain barrier disruption.
Correlation of diffusion and metabolic alterations in different clinical forms of multiple sclerosis.
[Natalizumab and reduction of carbonylated proteins in patients with multiple sclerosis].
Dendrimer-based postnatal therapy for neuroinflammation and cerebral palsy in a rabbit model.
[2012: Update on diagnosis and treatment of multiple sclerosis].
Associations of alcohol consumption with clinical and MRI measures in multiple sclerosis.
Protective effect of tanreqing injection on axon myelin damage in the brain of mouse model for experimental autoimmune encephalomyelitis.
Endogenous opioids regulate expression of experimental autoimmune encephalomyelitis: a new paradigm for the treatment of multiple sclerosis.
Does risk stratification decrease the risk of natalizumab-associated PML? Where is the evidence?
Magnetic Resonance Imaging in Balo's Concentric Sclerosis. A Case Report.
Changes in Fatigue and Cognition in Patients with Relapsing Forms of Multiple Sclerosis Treated with Natalizumab: The ENER-G Study.
Renin-angiotensin system gene polymorphisms as risk factors for multiple sclerosis.
Effects of interferon beta-1b on cognitive performance in patients with a first event suggestive of multiple sclerosis.
Motor vehicle operation in the setting of multiple sclerosis with myelopathy: assessment, adaptive equipment, counseling, and cessation of driving.
Deletion of IL-4Rα in the BALB/c mouse is associated with altered lesion topography and susceptibility to experimental autoimmune encephalomyelitis.
Prevention and diminished expression of experimental autoimmune encephalomyelitis by low dose naltrexone (LDN) or opioid growth factor (OGF) for an extended period: Therapeutic implications for multiple sclerosis.
What to expect after natalizumab cessation in a real-life setting.
Psychiatric symptoms in patients with multiple sclerosis.
T cell vaccination benefits relapsing progressive multiple sclerosis patients: a randomized, double-blind clinical trial.
[Chronic cerebrospinal venous insufficiency--pathophysiology and treament].

Pages